Anxiety & Behavioral Health
Generalized Anxiety Disorder (GAD)
Generalized Anxiety Disorder (GAD) affects millions of people worldwide, causing persistent and excessive worry that can interfere with daily life. CenExel partners with sponsors to advance innovative treatments for anxiety disorders through patient-focused psychiatric clinical research across adolescent, adult, and senior populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Advancing Clinical Research for Generalized Anxiety Disorder
CenExel’s psychiatry and behavioral health teams specialize in conducting high-quality clinical trials focused on Generalized Anxiety Disorder and related conditions. Our experienced investigators and operational experts provide efficient study execution, diverse patient recruitment, and scientifically rigorous outcomes from first-patient-in through study completion.
Conditions Covered
Anxiety & Related Disorders We Research
Our psychiatry research sites support a broad range of anxiety and behavioral health indications across multiple patient populations.
- Generalized Anxiety Disorder (GAD)
- Social Anxiety Disorder
- Panic Disorder
- Post-Traumatic Stress Disorder (PTSD)
- Major Depressive Disorder (MDD)
- Obsessive-Compulsive Disorder (OCD)
- Anxiety-Related Insomnia
- Pediatric Anxiety Disorders
Our Approach
Why Sponsors Choose CenExel for GAD Research
Experienced investigators with deep expertise in anxiety and behavioral health research.
01
Expert Psychiatry Investigators
Our experienced investigators provide deep expertise in anxiety disorders, patient care, and psychiatric trial execution.
02
Rapid Patient Recruitment
Access to diverse patient populations across multiple U.S. research sites.
03
Proven Trial Execution
Operational excellence supporting Phase I–IV psychiatric clinical studies.
04
Patient-Centered Care
Compassionate and supportive environments designed for participants with anxiety-related conditions.
Phase Coverage
Supported Anxiety Research Trial Phases
CenExel supports early and late-phase anxiety disorder clinical trials, from proof-of-concept studies through Phase IV post-market research.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our psychiatry research network supports biomarker strategies, decentralized trial components, and patient-focused study execution for anxiety-related indications.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.
